ProPhase Labs
Lance Bisesar, CPA, currently serves as the Head of Finance at ProPhase Labs. Previously, Lance held significant finance roles at several reputable companies, including Assistant Controller at Clover Health, Senior Director of Finance at CooperSurgical, and multiple positions at Casper, where responsibilities included Senior Director and Assistant Controller, as well as Director and Assistant Controller. Earlier experience includes serving as Manager of Financial Reporting and Technical Accounting at Colgate-Palmolive. Lance Bisesar's educational background includes pursuing a degree at Columbia Business School from 2026 and obtaining a Bachelor of Business Administration in Accounting from Hofstra University between 2003 and 2007.
This person is not in any teams
ProPhase Labs
ProPhase Labs Inc. (Nasdaq: PRPH) (“ProPhase”) is a next-generation biotech, genomics and diagnostics company. Our goal is to create a healthier world with bold action and the power of insight. We’re revolutionizing healthcare with industry-leading Whole Genome Sequencing solutions, while developing potential game changer diagnostics and therapeutics in the fight against cancer. This includes a potentially life-saving cancer test focused on early detection of esophageal cancer and potential breakthrough cancer therapeutics with novel mechanisms of action. Our world-class CLIA labs and cutting-edge diagnostic technology provide wellness solutions for healthcare providers and consumers. We develop, manufacture, and commercialize health and wellness solutions to enable people to live their best lives. We are committed to executional excellence, smart diversification, and a synergistic, omni-channel approach.